Skip to main content
Edmund Waller, MD, Oncology, Atlanta, GA, Emory University Hospital

EdmundKWallerMD

Oncology Atlanta, GA

Hematologic Oncology

Professor of Hematology & Oncology, Emory University

Dr. Waller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Waller's full profile

Already have an account?

Summary

  • Dr. Edmund Waller is a hematologist oncologist in Atlanta, GA and is affiliated with multiple hospitals in the area, including Emory University Hospital, Emory University Hospital Midtown, and Grady Memorial Hospital. He received his medical degree from Weill Cornell Medical College of Cornell University and his PhD from Rockefeller University. Following clinical training in Medicine and Medical Oncology at Stanford University and working at Becton Dickinson in San Jose, he has been in practice at Emory for 27 years. He manages an active R01 and P01-funded basic science and translational research laboratory. He has founded two biotech start-ups, Cambium Medical Technologies, a clinical stage company developing Elate Ocular to treat ocular GvHD, and Cambium Oncology, a pre-clinical company developing first-in-class antagonists of a novel immune check-point pathway mediated by signaling through the receptor for vasoactive intestinal polypeptide (VIP). He has clinical expertise in hematologic oncology, cancer immunotherapy, CART, and hematopoietic stem cell transplantation for lymphoma, myeloid malignancies, sickle cell anemia and germ cell cancer. He is the founding editor of ImmunoMedicine, a prolific contributor to the scientific literature, and active in review of scientific manuscripts and grants.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1988 - 1993
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1985 - 1988
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1985
  • Rockefeller University
    Rockefeller UniversityPhD, Chemical Biology, 1978 - 1984
  • Harvard College
    Harvard CollegeAB, Biology, Magna Cum Laude, 1974 - 1978

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 1995 - 2023
  • TX State Medical License
    TX State Medical License 1993 - 1995
  • CA State Medical License
    CA State Medical License 1987 - Present
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2022
  • America's Top Doctors for Cancer Castle Connolly, 2011-2022

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Potential of CAR T Cell Therapy in Pancreatic Cancer  
    Mehmet Akce, Mohammad Y Zaidi, Edmund K Waller, Frontiers in Neurology
  • Recipient Single Nucleotide Polymorphisms in Paneth Cell Antimicrobial Peptide Genes and Acute Graft‐Versus‐Host Disease: Analysis of BMT CTN‐0201 and ‐0901 Samples  
    Armin Rashidi, Edmund K Waller, Bharat Thyagarajan, Claudio Anasetti, Daniel J Weisdorf, Bart L Scott, Bruce R Blazar, British Journal of Haematology
  • Indoles Derived from Intestinal Microbiota Act via Type I Interferon Signaling to Limit Graft-Versus-Host-Disease  
    Edmund K Waller, Zachariah DeFilipp, Muna Qayed, Akshay Sharma, Blood

Abstracts/Posters

  • Outcomes of Elderly Patients Undergoing Allogeneic Transplantation for Acute Myeloid Leukemia with Fludarabine/Melphalan or Fludarabine/TBI Conditioning Regimen
    Edmund K. Waller, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizu...
    Edmund K. Waller, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Impact of Tisagenlecleucel Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Attributes on Clinical Outcomes in Adults with Relapsed or Refractory Diffuse Large B...
    Edmund K. Waller, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial o... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • NIAID Supports Clinical Testing of Anti-Cancer Drug for TB
    NIAID Supports Clinical Testing of Anti-Cancer Drug for TBAugust 15th, 2017
  • Transformative Award from NIH Supports Research on Malleable Cells
    Transformative Award from NIH Supports Research on Malleable CellsOctober 7th, 2015
  • Did A Study Overreach When It Said A Vaccine Prevents Leukemia?
    Did A Study Overreach When It Said A Vaccine Prevents Leukemia?May 27th, 2015
  • Join now to see all

Grant Support

  • Using donor dendritic cells to optimize GvHD and GvL in allogeneic stem cell transplantationNIH/NCI/NHLBI2020–2025
  • Development of Gleevec for TB and TB/HIVNIH/NIAID2015–2022
  • Modified Donor Lymphocytes Infusion (MDLI) For Rapid Immune ReconstitutionNational Heart, Lung, And Blood Institute2011
  • Immunologic And Virologic Monitoring Laboratory CoreNational Heart, Lung, And Blood Institute2011
  • Clinical Trials- Shared ResourcesNational Cancer Institute2009–2011
  • Separating Antitumor &Gvhd In Allogeneic T-CellsNational Cancer Institute2003–2007
  • Adoptive Transfer Of Immunity In Bone Marrow TransplantationNational Center For Research Resources1999–2002
  • Antileukemic Effect Of Irradiated Allogeneic LymphocytesNational Cancer Institute1998–2000

Committees

  • Member, NCI Leukemia Committee 2018 - Present

Professional Memberships

Hospital Affiliations